Uncontrolled Lower Respiratory Symptoms in the World Trade Center Survivor Program

Trial Profile

Uncontrolled Lower Respiratory Symptoms in the World Trade Center Survivor Program

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Oct 2017

At a glance

  • Drugs Salmeterol/fluticasone propionate (Primary)
  • Indications Respiratory tract disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Oct 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Feb 2018.
    • 10 Jun 2017 Biomarkers information updated
    • 26 Sep 2016 Planned End Date changed from 1 Nov 2016 to 1 Nov 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top